STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 93 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $545,000 | -92.5% | 42,396 | -94.4% | 1.68% | -77.0% |
| Q4 2018 | $7,248,000 | -69.9% | 762,941 | -47.4% | 7.29% | -51.4% |
| Q3 2018 | $24,098,000 | +2.0% | 1,451,700 | -1.3% | 15.01% | +78.7% |
| Q2 2018 | $23,618,000 | +24.4% | 1,471,518 | +18.5% | 8.40% | +37.3% |
| Q1 2018 | $18,992,000 | +46.8% | 1,241,293 | +49.7% | 6.12% | +41.8% |
| Q4 2017 | $12,934,000 | +115.2% | 829,090 | +53.1% | 4.31% | +86.1% |
| Q3 2017 | $6,010,000 | +420.3% | 541,462 | +331.1% | 2.32% | +398.3% |
| Q2 2017 | $1,155,000 | – | 125,595 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 762,941 | $7,248,000 | 7.29% |
| NEXTHERA CAPITAL LP | 711,558 | $6,760,000 | 2.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 585,930 | $4,366,000 | 2.71% |
| Consonance Capital Management LP | 1,155,793 | $10,980,000 | 0.81% |
| Pier Capital, LLC | 423,667 | $4,025,000 | 0.80% |
| KNOTT DAVID M | 155,795 | $1,480,000 | 0.70% |
| Eventide Asset Management | 1,086,400 | $10,321,000 | 0.46% |
| Empire Life Investments Inc. | 373,863 | $3,552,000 | 0.32% |
| Telemetry Investments, L.L.C. | 41,588 | $395,000 | 0.25% |
| Polar Capital LLP | 2,302,666 | $21,875,000 | 0.23% |